NASDAQ : BTSG
BrightSpring Health Services, Inc. — Key statistics
Healthcare · Health Information Services · United States
Last price 60.22 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 12.55B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 13.93B |
| Enterprise Value | 15.60B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 30, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 196.59M |
| Shares Outstanding | 208.32M |
| Shares Change (YoY) | +3.57% |
| Shares Change (QoQ) | -0.02% |
| Owned by Insiders (%) | 1.14% |
| Owned by Institutions (%) | 93.38% |
| Float | 152.23M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 36.28 |
| Forward PE | 29.49 |
| PS Ratio | 0.91 |
| Forward PS | 0.80 |
| PB Ratio | 6.36 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 28.30 |
| P/OCF Ratio | 23.12 |
| PEG Ratio | 0.55 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 38.01 |
| EV / Sales | 1.02 |
| EV / EBITDA | 22.48 |
| EV / EBIT | 29.13 |
| EV / FCF | 31.67 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.62 |
| Quick Ratio | 1.21 |
| Debt / Equity | 1.09 |
| Debt / EBITDA | 3.10 |
| Debt / FCF | 4.83 |
| Interest Coverage | 3.69 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 15.54% |
| Return on Assets (ROA) | 5.43% |
| Return on Invested Capital (ROIC) | 11.47% |
| Return on Capital Employed (ROCE) | 11.75% |
| Weighted Average Cost of Capital (WACC) | 13.19% |
| Revenue Per Employee | $648,967 |
| Profits Per Employee | $17,459 |
| Employee Count | 23,500 |
| Asset Turnover | 2.48 |
| Inventory Turnover | 20.36 |
Taxes
| Measure | Value |
|---|
| Income Tax | 64.13M |
| Effective Tax Rate | 17.08% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.88 |
| 52-Week Price Change | +96.45% |
| 50-Day Moving Average | 59.94 |
| 200-Day Moving Average | 54.69 |
| Relative Strength Index (RSI) | 67.26 |
| Average Volume (20 Days) | 2,236,393 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 11.47M |
| Short Previous Month | 11.98M |
| Short % of Shares Out | 5.51% |
| Short % of Float | 7.54% |
| Short Ratio (days to cover) | 4.68 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 15.25B |
| Gross Profit | 1.91B |
| Operating Income | 535.46M |
| Pretax Income | 375.37M |
| Net Income | 410.28M |
| EBITDA | 693.87M |
| EBIT | 535.46M |
| Earnings Per Share (EPS) | $1.84 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 717.84M |
| Total Debt | 2.38B |
| Net Cash | -1.66B |
| Net Cash Per Share | -$7.97 |
| Equity (Book Value) | 2.19B |
| Book Value Per Share | 10.51 |
| Working Capital | 1.05B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 602.74M |
| Capital Expenditures | -110.33M |
| Depreciation & Amortization | 158.41M |
| Net Borrowing | -355.64M |
| Free Cash Flow | 492.41M |
| FCF Per Share | $2.36 |
Margins
| Measure | Value |
|---|
| Gross Margin | 12.50% |
| Operating Margin | 3.51% |
| Pretax Margin | 2.46% |
| Profit Margin | 2.69% |
| EBITDA Margin | 4.55% |
| EBIT Margin | 3.51% |
| FCF Margin | 3.23% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -3.57% |
| Shareholder Yield | -3.57% |
| Earnings Yield | 2.76% |
| FCF Yield | 3.53% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $81.91 |
| Price Target Difference | 22.46% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 18 |
| Revenue Growth Forecast (3Y) | 16.55% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 4.41 |
| Piotroski F-Score | 7 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |